Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament

Complexo Hospitalario Universitario de Santiago, Spain
PLoS ONE (Impact Factor: 3.23). 08/2014; 9(8):e104534. DOI: 10.1371/journal.pone.0104534


Endocannabinoids and temperament traits have been linked to both physical activity and body mass index (BMI) however no study has explored how these factors interact in females. The aims of this cross-sectional study were to 1) examine differences among distinct BMI groups on daytime physical activity and time spent in moderate-vigorous physical activity (MVPA), temperament traits and plasma endocannabinoid concentrations; and 2) explore the association and interaction between MVPA, temperament, endocannabinoids and BMI.

Physical activity was measured with the wrist-worn accelerometer Actiwatch AW7, in a sample of 189 female participants (43 morbid obese, 30 obese, and 116 healthy-weight controls). The Temperament and Character Inventory-Revised questionnaire was used to assess personality traits. BMI was calculated by bioelectrical impedance analysis via the TANITA digital scale. Blood analyses were conducted to measure levels of endocannabinoids and endocannabinoid-related compounds. Path-analysis was performed to examine the association between predictive variables and MVPA.

Obese groups showed lower MVPA and dysfunctional temperament traits compared to healthy-weight controls. Plasma concentrations of 2-arachidonoylglyceryl (2-AG) were greater in obese groups. Path-analysis identified a direct effect between greater MVPA and low BMI (b = −0.13, p = .039) and high MVPA levels were associated with elevated anandamide (AEA) levels (b = 0.16, p = .049) and N-oleylethanolamide (OEA) levels (b = 0.22, p = .004), as well as high Novelty seeking (b = 0.18, p<.001) and low Harm avoidance (b = −0.16, p<.001).

Obese individuals showed a distinct temperament profile and circulating endocannabinoids compared to controls. Temperament and endocannabinoids may act as moderators of the low MVPA in obesity.

Download full-text


Available from: Sarah Sauchelli Toran, Aug 11, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim: We examined endocannabinoids (ECs) in relation to bariatric surgery and the association between plasma ECs and markers of insulin resistance. Methods: A study of 20 participants undergoing bariatric surgery. Fasting and 2-hour plasma glucose, lipids, insulin, and C-peptide were recorded preoperatively and 6 months postoperatively with plasma ECs (AEA, 2-AG) and endocannabinoid-related lipids (PEA, OEA). Results: Gender-specific analysis showed differences in AEA, OEA, and PEA preoperatively with reductions in AEA and PEA in females postoperatively. Preoperatively, AEA was correlated with 2-hour glucose (r = 0.55, P = 0.01), HOMA-IR (r = 0.61, P = 0.009), and HOMA %S (r = -0.71, P = 0.002). OEA was correlated with weight (r = 0.49, P = 0.03), waist circumference (r = 0.52, P = 0.02), fasting insulin (r = 0.49, P = 0.04), and HOMA-IR (r = 0.48, P = 0.05). PEA was correlated with fasting insulin (r = 0.49, P = 0.04). 2-AG had a negative correlation with fasting glucose (r = -0.59, P = 0.04). Conclusion: Gender differences exist in circulating ECs in obese subjects. Females show changes in AEA and PEA after bariatric surgery. Specific correlations exist between different ECs and markers of obesity and insulin and glucose homeostasis.
    Journal of Diabetes Research 03/2015; 2015. DOI:10.1155/2015/680867 · 2.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: There is compelling evidence in humans that peripheral endocannabinoid signaling is disrupted in obesity. However, little is known about the corresponding central signaling. Here, we have investigated the relationship between gender, leptin, body mass index (BMI) and levels of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in the serum and cerebrospinal fluid (CSF) of primarily overweight to obese patients with osteoarthritis. Methodology/principal findings: Patients (20 females, 15 males, age range 44-78 years, BMI range 24-42) undergoing total knee arthroplasty for end-stage osteoarthritis were recruited for the study. Endocannabinoids were quantified by liquid chromatography - mass spectrometry. AEA and 2-AG levels in the serum and CSF did not correlate with either age or BMI. However, 2-AG levels in the CSF, but not serum, correlated negatively with CSF leptin levels (Spearman's ρ -0.48, P=0.0076, n=30). No such correlations were observed for AEA and leptin. Conclusions/significance: In the patient sample investigated, there is a negative association between 2-AG and leptin levels in the CSF. This is consistent with pre-clinical studies in animals, demonstrating that leptin controls the levels of hypothalamic endocannabinoids that regulate feeding behavior.
    PLoS ONE 04/2015; 10(4):e0123132. DOI:10.1371/journal.pone.0123132 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Une session d’exercice aérobie modérée ou intense est capable d’augmenter les concentrations plasmatiques d’un des ligands du système endocannabinoïde, l’anandamide (AEA) alors que celles de sn-2-arachidonylglycérol (2-AG) ne varient pas. Quelques études in vitro suggèrent un effet bénéfique possible de l’AEA sur le métabolisme musculaire (e.g. sensibilité à l’insuline et biogenèse mitochondriale) via une action sur des récepteurs non cannabinoïdes – les récepteurs aux cannabinoïdes CB1 ayant au contraire des effets métaboliques délétères. Ces CB1 pourraient être hyperactivés dans certains tissus périphériques dans le cadre de l’obésité et l’exercice chronique pourrait alors en réduire l’expression (e.g. dans le tissu adipeux viscéral). Au niveau central, les études chez l’animal montrent que l’activation des CB1 en réponse à l’entraînement pourrait augmenter la prolifération cellulaire hippocampale et la mémoire spatiale. Enfin, l’activation des CB1 dans le striatum et le mésencéphale pourrait participer respectivement au phénomène d’addiction à l’exercice et à l’effet analgésique de ce dernier.
    Cahiers de Nutrition et de Diététique 04/2015; DOI:10.1016/j.cnd.2015.04.001